Casale Robert Daniel 4
4 · Adams Respiratory Therapeutics, Inc. · Filed Feb 2, 2007
Insider Transaction Report
Form 4
Casale Robert Daniel
EVP, Chief Mktg & Devel. Off.
Transactions
- Sale
Common Stock
2007-02-01$44.80/sh−526$23,565→ 1,474 total - Sale
Common Stock
2007-02-01$44.86/sh−33$1,480→ 1,441 total - Sale
Common Stock
2007-02-01$44.89/sh−200$8,978→ 1,241 total - Exercise/Conversion
Common Stock
2007-02-01$1.42/sh+2,000$2,840→ 2,000 total - Sale
Common Stock
2007-02-01$44.90/sh−241$10,821→ 1,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-02-01−2,000→ 65,960 totalExercise: $1.42Exp: 2014-02-27→ Common Stock (2,000 underlying) - Sale
Common Stock
2007-02-01$44.94/sh−1,000$44,940→ 0 total
Footnotes (2)
- [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2005.
- [F2]The options vest in pro rata monthly installments over five years, beginning on April 1, 2004.